Other equities research analysts have also issued research reports about the company. Buckingham Research boosted their price target on Under Armour from $18.00 to $20.00 and gave the stock a neutral rating in a research note on Wednesday. Credit Suisse Group boosted their price target on Under Armour from $23.00 to $26.00 and gave the stock a neutral rating in a research note on Wednesday. Canaccord Genuity boosted their price target on Under Armour from $12.00 to $13.00 and gave the stock a sell rating in a research note on Wednesday. ValuEngine upgraded Under Armour from a sell rating to a hold rating in a research note on Friday, August 10th. Finally, B. Riley reiterated a sell rating on shares of Under Armour in a research report on Friday, July 27th. Seven analysts have rated the stock with a sell rating, thirteen have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $19.36.
Shares of UAA stock traded up $1.18 during trading hours on Wednesday, reaching $23.29. 6,410,812 shares of the company’s stock were exchanged, compared to its average volume of 5,941,763. Under Armour has a 1 year low of $11.40 and a 1 year high of $24.69. The firm has a market capitalization of $10.34 billion, a price-to-earnings ratio of 122.56, a PEG ratio of 5.63 and a beta of -0.42. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.94 and a current ratio of 1.99.
A number of large investors have recently made changes to their positions in UAA. Point72 Hong Kong Ltd lifted its holdings in Under Armour by 813.9% in the second quarter. Point72 Hong Kong Ltd now owns 5,849 shares of the company’s stock valued at $131,000 after acquiring an additional 5,209 shares during the period. NEXT Financial Group Inc acquired a new position in shares of Under Armour during the 3rd quarter worth approximately $138,000. Exane Derivatives raised its stake in shares of Under Armour by 15,240.0% during the 3rd quarter. Exane Derivatives now owns 6,903 shares of the company’s stock worth $148,000 after buying an additional 6,858 shares during the period. Cerebellum GP LLC acquired a new position in shares of Under Armour during the 2nd quarter worth approximately $171,000. Finally, Tower Research Capital LLC TRC raised its stake in shares of Under Armour by 119.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 8,921 shares of the company’s stock worth $201,000 after buying an additional 4,848 shares during the period. 36.87% of the stock is owned by institutional investors.
About Under Armour
Under Armour, Inc, together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes.
Featured Story: How to Invest in a Bull Market
Receive News & Ratings for Under Armour Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Under Armour and related companies with MarketBeat.com's FREE daily email newsletter.